News

The composite primary efficacy endpoint of the trial was ‘complete cure’ defined as negative mycology and clear nail. EcoNail is the company’s patented, topically-applied lacquer which contains the

The Peak surgery system combines the Pulsar Generator, which supplies pulsed plasma radiofrequency energy, with the Peak PlasmaBlade 4.0, a low-temperature surgical cutting and coagulation tool. This tissue

The round was led by new investor, Devon Park Bioventures, and included participation by Connecticut Innovations. Previous investors participating in the round included; Ascent Biomedical Ventures, Mitsubishi International

The approval of Apidra for pediatric use provides children with the option of using Apidra as part of their overall diabetes treatment plan, usually in combination with basal

The approved clinical trial will be open to patients with a variety of tumor types who have failed previous therapies. It will be conducted at a limited number

Proteros applied its industrial structural biology platform and proprietary technologies to deliver protein ligand structures to Almirall Scientists for a known, extremely challenging protein where little published data

The Risperdal Consta uses Alkermes’s proprietary Medisorb technology to deliver and maintain therapeutic medication levels in the body through just one injection every two weeks. Available in 12.5mg,

The financing was led by investments from two venture capital funds: Quaker BioVentures and SR One, the venture capital arm of GlaxoSmithKline. Previous investors, Safeguard Scientifics, Bay City

NuVasive is making a closing payment of $35 million in cash. Osiris will continue to supply Osteocel to NuVasive for a period of 18 months following the closing,